<DOC>
	<DOC>NCT00092677</DOC>
	<brief_summary>The purpose of this study is to evaluate whether treatment with an investigational drug as compared to placebo will reduce the risk of major cardiovascular events in patients with aortic stenosis.</brief_summary>
	<brief_title>An Investigational Drug on Clinical Outcomes in Patients With Aortic Stenosis (Narrowing of the Major Blood Vessel of the Heart)(MK-0653A-043 AM4)(COMPLETED)</brief_title>
	<detailed_description />
	<mesh_term>Constriction, Pathologic</mesh_term>
	<mesh_term>Aortic Valve Stenosis</mesh_term>
	<mesh_term>Ezetimibe</mesh_term>
	<mesh_term>Simvastatin</mesh_term>
	<criteria>Patients aged 45 to 85 with mild abnormalities of the aortic valve as confirmed by an echocardiogram. Patients previously in a trial using the study drug, or currently taking any medications that are not allowed in this study.</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>